Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/31/2025

Differential Diagnosis of Lymphocytic Pleocytosis

Etiologies and Diagnostic Considerations

  • Enterovirus infections, particularly EV-71, should be considered in patients with lower cranial nerve involvement, as they can cause lymphocytic pleocytosis 1
  • Tuberculous meningitis, fungal infections, and Listeria monocytogenes should be considered in patients with subacute presentation, immunocompromised state, or endemic exposure, as they can produce lymphocytic pleocytosis 2
  • Listeria monocytogenes accounts for 5% of bacterial meningitis overall but 20-40% in immunocompromised patients, elderly, diabetics, and those on immunosuppressive therapy, and can present with lymphocytic predominance 2
  • Mild-to-moderate CSF abnormalities with lymphocytic predominance occur in 50-70% of cases of neuropsychiatric SLE, and anti-NMDA receptor encephalitis and other autoimmune encephalitides should be considered when psychiatric symptoms, seizures, or movement disorders are prominent 3, 4, 5
  • Neurosarcoidosis and Behçet's disease can present with lymphocytic meningitis, and consideration of these diagnoses is crucial in patients with appropriate clinical context 5
  • Neuroborreliosis (Lyme disease) presents with lymphocytic pleocytosis and should be considered in endemic areas with appropriate exposure history 5

Diagnostic Algorithm and Treatment

  • If bacterial meningitis cannot be definitively excluded, start empiric antibiotics immediately, including ceftriaxone + vancomycin + ampicillin if >50 years or immunocompromised, as recommended by the Infectious Diseases Society of America 2
  • Treatment should begin within one hour of presentation when bacterial meningitis is suspected, as delayed treatment can lead to poor outcomes 2
  • Listeria is resistant to cephalosporins, and ampicillin must be added for patients >50 years, immunocompromised, or pregnant, according to the guidelines from the Infectious Diseases Society of America 2

Additional Studies and Pitfalls to Avoid

  • Brain MRI with contrast should be performed to evaluate for parenchymal involvement, abscess, or autoimmune patterns, as recommended by the American Academy of Neurology 5
  • Autoimmune encephalitis antibody panel (NMDA, LGI1, GFAP, etc.) should be considered if clinical features suggest autoimmune etiology, as suggested by the Autoimmune Encephalitis Association 5
  • Serum testing, including HIV, ANA, ENA, ACE (for sarcoidosis), and Lyme serology, should be performed based on clinical context, as recommended by the American College of Rheumatology 5

Lymphocytic Pleocytosis Diagnosis and Management

Definition and Characteristics

  • Lymphocytic pleocytosis is an abnormal increase in white blood cells in the cerebrospinal fluid (CSF), specifically with lymphocytes as the predominant cell type, typically defined as more than 5 lymphocytes per microliter, according to the Centers for Disease Control and Prevention (CDC) 6, 7, 8
  • Pleocytosis refers to an elevated white blood cell count in the CSF above normal levels (typically >5 cells/µL), as defined by the Infectious Diseases Society of America 7, 8
  • The cell count can range from mild elevations (tens of cells) to several hundred cells per microliter, depending on the underlying cause, as reported by the CDC 6, 8

Clinical Significance

  • Viral infections, such as Herpes simplex virus (HSV) encephalitis, Varicella-zoster virus (VZV), Epstein-Barr virus (EBV), and cytomegalovirus (CMV), are common causes of lymphocytic pleocytosis, according to the Infectious Diseases Society of America 7, 8
  • Non-viral causes, including Tuberculosis meningitis, Listeriosis, and partially treated bacterial meningitis, can also produce lymphocytic pleocytosis, as reported by the CDC and the Infectious Diseases Society of America 7, 8
  • Fungal infections, such as histoplasmosis, coccidioidomycosis, and cryptococcosis, typically produce lymphocytic pleocytosis, according to the CDC 9, 10, 11
  • Tickborne rickettsial diseases, such as Rocky Mountain Spotted Fever and ehrlichiosis, can cause either neutrophilic or lymphocytic pleocytosis, as reported by the CDC 6, 12

Diagnostic Distinctions

  • Normal glucose with lymphocytic pleocytosis suggests viral infection, according to the Infectious Diseases Society of America 7, 8
  • Low CSF:plasma glucose ratio (<0.5) with lymphocytic pleocytosis suggests tuberculosis, fungal infection, or partially treated bacterial meningitis, as reported by the Infectious Diseases Society of America 7, 8
  • Elevated protein (100-200 mg/dL) is common in many causes of lymphocytic pleocytosis, according to the CDC and the Infectious Diseases Society of America 6, 8
  • CSF lactate <2 mmol/L effectively rules out bacterial disease, as reported by the Infectious Diseases Society of America 7, 8

Elevated Nucleated Cells in CSF: Clinical Significance and Diagnostic Approach

Critical First Step: Cell Differential Analysis

  • 10% of bacterial meningitis patients have fewer than 100 cells per mm³, especially early in the illness, according to the Journal of Infection 13
  • Some bacterial meningitis cases, such as Listeria, may show lymphocytic predominance 13
  • Neutrophil predominance may occur in early viral meningitis, though total CSF white cell count is unlikely to exceed 2000 cells per mm³ 13

Management of Nucleated Cells in Cerebrospinal Fluid

Diagnostic Approach

  • The American College of Physicians recommends obtaining a manual cell differential immediately to distinguish neutrophilic from lymphocytic predominance, as this fundamentally changes management 14
  • Neutrophilic predominance (>50% neutrophils) suggests bacterial meningitis and requires immediate empiric antibiotics, according to the Infectious Diseases Society of America 14
  • The Infectious Diseases Society of America suggests that HSV-1/2, VZV, enterovirus PCR should be performed immediately, with a sensitivity of 96-98% for HSV in adults and 75-100% in neonates 14
  • The National Comprehensive Cancer Network recommends that leptomeningeal metastases require cytologic analysis of CSF with adequate volume, and cytology may be negative on first sample, requiring repeat sampling from both lumbar and ventricular sites 15
  • The National Comprehensive Cancer Network states that neoplastic meningitis presents with multifocal neurologic deficits, and median survival untreated is 4-6 weeks 15
  • Flow cytometry improves detection of malignant cells beyond routine cytology, according to the National Comprehensive Cancer Network 15
  • The American Academy of Neurology recommends that EEG is sensitive for cerebral dysfunction and essential for detecting nonconvulsive seizures in confused or obtunded patients 14
  • Rapidly improving EEG findings indicate good prognosis, according to the American Academy of Neurology 14
  • Repeat lumbar puncture at 48-72 hours if diagnosis remains unclear and patient not improving, as suggested by the Infectious Diseases Society of America 14

BioFire FilmArray Meningitis/Encephalitis Panel: Evidence‑Based Guideline Summary

Integration with IDSA Recommendations

  • The BioFire ME panel supplements the Infectious Diseases Society of America (IDSA) comprehensive CSF work‑up rather than replacing it, providing rapid multiplex results while traditional culture and susceptibility testing remain essential. [16][17]18
  • Traditional bacterial culture must still be performed because it yields antimicrobial susceptibility data that the molecular panel cannot provide. [16][17]

Indications for Ordering the Panel

  • Broad differential diagnoses: When the clinical picture could be caused by many pathogens, multiplex testing is more efficient than ordering numerous single‑target PCRs. 19
  • Prior antibiotic exposure: In a study, 75 % of patients with true‑positive panel results had received antibiotics before lumbar puncture, and 27 % of cases would have remained pathogen‑negative without the panel. This addresses the IDSA observation that many meningitis cases stay unexplained after standard testing. [16][20]
  • Pathogens not covered by routine panels: For suspected atypical agents such as Mycobacterium tuberculosis, Borrelia burgdorferi, or Treponema pallidum, the panel’s limited coverage necessitates additional targeted tests. [19][16]

Limitations and Pitfalls

  • False‑positive risk: Approximately one‑third of false‑positive results in one cohort involved Streptococcus agalactiae. Positive results should always be correlated with CSF cell count, glucose, protein, and clinical presentation. 19
  • Low sensitivity for cryptococcal infection: The panel’s sensitivity drops markedly at low fungal burdens; a negative result does not exclude cryptococcal meningitis in immunocompromised patients, so cryptococcal antigen testing and fungal culture are required. 19
  • Incomplete pathogen coverage: While Listeria monocytogenes is included, the panel does not detect M. tuberculosis, Borrelia, Treponema, or most fungi, necessitating supplemental testing in relevant clinical contexts. [19][16]
  • Detection of latent or shedding viruses: Identification of enterovirus or HHV‑6 may reflect asymptomatic shedding rather than true CNS infection; results must be interpreted alongside epidemiologic and clinical clues. 19

Interpretation and Clinical Decision‑Making

  • Clinical judgment is essential: Multiplex PCR’s unbiased nature makes it prone to detecting contaminants, colonizers, or latent viruses; clinicians should integrate results with exposure history, seasonality, vaccination status, and neurological findings as emphasized by IDSA guidelines. [16][21]18
  • Do not delay empiric therapy: Empiric antibiotics (e.g., ceftriaxone + vancomycin ± ampicillin) should be started promptly when bacterial meningitis cannot be excluded; the panel’s result can later guide de‑escalation.

Emerging Role and Future Considerations

  • Multiplex PCR platforms like the BioFire ME panel are promising for expanding rapid diagnostics, but clinicians must remain cautious about variable pathogen detection timelines (e.g., flaviviruses, HSV) and consider alternative specimens for certain viruses (e.g., enteroviruses). 19
  • As availability increases, these tools are expected to play a larger role in diagnostically challenging cases, complementing emerging technologies such as next‑generation sequencing. 19

Management of Suspected Post‑Infectious Viral Meningoencephalitis with Status Epilepticus

Diagnosis

Immediate Empiric Therapy (within 1 hour)

Diagnostic Workup

Antibiotic De‑escalation and Antiviral Duration

REFERENCES

15

leptomeningeal metastases: current concepts and management guidelines. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2005

19

update and new insights in encephalitis. [LINK]

Clinical Microbiology and Infection, 2017